CD147 and cyclophilin A: a promising potential targeted therapy for COVID-19 and associated cancer progression and chemo-resistance

Coronavirus disease-2019 (COVID-19), as a worldwide serious issue has been shown to lead to progression and poor outcomes in cancer patients. The underlying mechanisms for SARS-CoV-2 infection’s adverse effects on cancer patients have not been fully understood. We hypothesized that CD147 and Cycloph...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhtiyari, Maryam, Haji Aghasi, Ayda, Banihashemi, Sara, Abbassioun, Arian, Tavakol, Chanour, Zalpoor, Hamidreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072013/
https://www.ncbi.nlm.nih.gov/pubmed/37016434
http://dx.doi.org/10.1186/s13027-023-00501-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10072013/
https://www.ncbi.nlm.nih.gov/pubmed/37016434
http://dx.doi.org/10.1186/s13027-023-00501-2

Ejemplares similares